The biomanufacturing industry is witnessing a significant shift as innovative microcarrier technologies emerge, promising to alter the conventional methods of cell-based production. At the forefront of this transformation is the collaboration between Smart MCs and the University of New South Wales
Drawing from years of experience in biopharmaceutical research and innovation, Ivan Kairatov is known for his insightful contributions to healthcare advancements. With the recent recognition of Tagomics Ltd. through a substantial grant from Innovate UK for colorectal cancer research, Ivan is poised
The prospect of biomanufacturing in space is accelerating the evolution of healthcare delivery and research in significant ways. From the unique research opportunities aboard the International Space Station (ISS) to the cutting-edge advancements in regenerative medicine, the potential of these
As the biopharmaceutical sector traverses the complex terrain of 2025, it encounters a multitude of challenges shaped by financial constraints, regulatory shifts, and evolving geopolitical dynamics. The industry is marked by notable changes detailed in Ernst & Young LLP's (EY) annual Biotech Beyond
Veranova has announced a major expansion of its Devens, Massachusetts facility, marking a significant step forward in the development and manufacturing of Antibody-Drug Conjugates (ADCs) and highly potent compounds. The company is investing $50 million to extend the facility by 9,000 square feet,
The biopharmaceutical industry finds itself at a crossroads as the ever-increasing global demand for pharmaceuticals necessitates a reevaluation of traditional manufacturing approaches. With escalating costs and inefficiencies hindering timely drug production, the sector is turning towards a